HRSMM
Jul 23, 2024
Understanding High Risk Smoldering Multiple Myeloma: A Bridge Between MGUS and Multiple Myeloma
Smoldering Multiple Myeloma (SMM) is an asymptomatic condition that acts as an intermediate stage between monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma. First described by Kyle and Greipp in 1980, SMM typically affects individuals aged 50 to 70 and is usually diagnosed incidentally ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
